Literature DB >> 20436270

Is there a telomere-bound 'EST' telomerase holoenzyme?

Diane C DeZwaan1, Brian C Freeman.   

Abstract

Eukaryotic linear chromosomes culminate in nucleoprotein structures designated telomeres. The terminal telomeric DNA consists of tandem repeats of a G-rich motif that is established and maintained by the action of the specialized reverse transcriptase telomerase. In addition to the core enzyme, effective replication of telomeric DNA requires a number of regulatory factors. In budding yeast, four components identified in the seminal Ever Shorter Telomere (EST) genetic screens constitute the keystone proteins that sustain telomeric DNA. Importantly, the EST proteins appear to be structurally conserved from yeast to human. The mechanism of telomerase recruitment and regulation, with an emphasis on the EST proteins, are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20436270     DOI: 10.4161/cc.9.10.11536

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  5 in total

Review 1.  Biogenesis of telomerase ribonucleoproteins.

Authors:  Emily D Egan; Kathleen Collins
Journal:  RNA       Date:  2012-08-08       Impact factor: 4.942

2.  CDK1 differentially regulates G-overhang generation at leading- and lagging-strand telomeres in telomerase-negative cells in G2 phase.

Authors:  Xueyu Dai; Chenhui Huang; Weihang Chai
Journal:  Cell Cycle       Date:  2012-08-08       Impact factor: 4.534

3.  RPA facilitates telomerase activity at chromosome ends in budding and fission yeasts.

Authors:  Pierre Luciano; Stéphane Coulon; Virginie Faure; Yves Corda; Julia Bos; Steven J Brill; Eric Gilson; Marie-Noelle Simon; Vincent Géli
Journal:  EMBO J       Date:  2012-02-21       Impact factor: 11.598

Review 4.  Finding the end: recruitment of telomerase to telomeres.

Authors:  Jayakrishnan Nandakumar; Thomas R Cech
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01-09       Impact factor: 113.915

5.  Cdc13 at a crossroads of telomerase action.

Authors:  Dmitri Churikov; Yves Corda; Pierre Luciano; Vincent Géli
Journal:  Front Oncol       Date:  2013-02-28       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.